Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$40.5M |
| 2 |
S&P Global
SPGI
|
+$30.2M |
| 3 |
Medtronic
MDT
|
+$25.3M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$23.2M |
| 5 |
Northrop Grumman
NOC
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$63.7M |
| 2 |
Conagra Brands
CAG
|
+$20.3M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$20M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$18.2M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 13.74% |
| 2 | Healthcare | 12.91% |
| 3 | Technology | 11.18% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TTPH
1651
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $83K | ﹤0.01% |
+1,033
| New | +$81.7K |
2016 Q4
0 quarters
|
|
|
TESO
1652
DELISTED
Tesco Corp
TESO
| $83K | ﹤0.01% |
+10,015
| New | +$79.3K |
2016 Q4
0 quarters
|
|
|
IMDZ
1653
DELISTED
Immune Design Corp.
IMDZ
| $83K | ﹤0.01% |
+15,042
| New | +$106K |
2016 Q4
0 quarters
|
|
1654
DELISTED
Everi Holdings
EVRI
| $81K | ﹤0.01% |
+37,200
| New | +$86.3K |
2016 Q4
0 quarters
|
|
1655
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $81K | ﹤0.01% |
+852
| New | +$73.6K |
2016 Q4
0 quarters
|
|
|
SRNE
1656
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $79K | ﹤0.01% |
+16,116
| New | +$96.8K |
2016 Q4
0 quarters
|
|
1657
DELISTED
Enzo Biochem, Inc.
ENZ
| $78K | ﹤0.01% |
+11,238
| New | +$71.7K |
2016 Q4
0 quarters
|
|
1658
DELISTED
Trevena, Inc.
TRVN
| $78K | ﹤0.01% |
21
-3
| -13% | -$10.7K |
2016 Q3
1 quarter
|
|
|
FNBC
1659
DELISTED
First NBC Bank Holding Company
FNBC
| $78K | ﹤0.01% |
+10,741
| New | +$84.9K |
2016 Q4
0 quarters
|
|
1660
QuinStreet
QNST
$1.09B
| $76K | ﹤0.01% |
+20,180
| New | +$65.5K |
2016 Q4
0 quarters
|
|
|
CALA
1661
DELISTED
Calithera Biosciences, Inc
CALA
| $76K | ﹤0.01% |
+1,170
| New | +$73.1K |
2016 Q4
0 quarters
|
|
|
ARNA
1662
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $76K | ﹤0.01% |
+5,362
| New | +$83.1K |
2016 Q4
0 quarters
|
|
|
PQ
1663
DELISTED
Petroquest Energy Inc Wd
PQ
| $75K | ﹤0.01% |
+22,800
| New | +$85.4K |
2016 Q4
0 quarters
|
|
|
ATTU
1664
DELISTED
Attunity Ltd
ATTU
| $75K | ﹤0.01% |
+12,500
| New | +$71.7K |
2016 Q4
0 quarters
|
|
1665
Commercial Vehicle Group
CVGI
$131M
| $74K | ﹤0.01% |
+13,300
| New | +$70.6K |
2016 Q4
0 quarters
|
|
1666
Kura Oncology
KURA
$673M
| $74K | ﹤0.01% |
+12,518
| New | +$67.1K |
2016 Q4
0 quarters
|
|
|
INFI
1667
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $74K | ﹤0.01% |
54,830
+36,330
| +196% | +$47.4K |
2015 Q4
4 quarters
|
|
|
QHC
1668
DELISTED
Quorum Health Corporation
QHC
| $74K | ﹤0.01% |
+10,164
| New | +$61.2K |
2016 Q4
0 quarters
|
|
1669
Franklin Master Intermediate Income Trust
PIM
$149M
| $73K | ﹤0.01% |
+15,800
| New | +$70K |
2016 Q4
0 quarters
|
|
|
AST
1670
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $72K | ﹤0.01% |
+15,690
| New | +$64.7K |
2016 Q4
0 quarters
|
|
|
CSLT
1671
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $71K | ﹤0.01% |
+14,300
| New | +$64.8K |
2016 Q4
0 quarters
|
|
1672
Aberdeen Government Markets Income Fund
MGF
$91.2M
| $70K | ﹤0.01% |
+2,780
| New | +$71.2K |
2016 Q4
0 quarters
|
|
1673
Companhia Siderúrgica Nacional
SID
$1.08B
| $70K | ﹤0.01% |
+21,823
| New | +$71K |
2016 Q4
0 quarters
|
|
1674
AXT Inc
AXTI
$2.58B
| $68K | ﹤0.01% |
+14,100
| New | +$72.6K |
2016 Q4
0 quarters
|
|
|
NIHD
1675
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $68K | ﹤0.01% |
31,480
+5,780
| +22% | +$13.6K |
2016 Q3
1 quarter
|
|
Similar funds
Squarepoint's Q4 2016 Portfolio in Review
As of Q4 2016, Squarepoint held 2,060 positions worth $2.44B, up 62% from $1.51B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $913M of net new capital in Q4 2016, opening 1,079 new positions and adding to 424 existing holdings. Its largest new stake was S&P Global: 252,484 shares worth $27.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Conagra Brands, an estimated $20.3M trimmed.
- Squarepoint's largest Q4 2016 buy was S&P Global: 252,484 shares worth $27.2M.
- Squarepoint added most to iShares China Large-Cap ETF in Q4 2016, an estimated $40.5M increase.
- Squarepoint's biggest Q4 2016 reduction was Conagra Brands, cutting an estimated $20.3M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q4 2016, selling an estimated $63.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $2.44B portfolio in Q4 2016.
- Squarepoint opened 1,079 new positions and closed 329 in Q4 2016.
- Squarepoint's portfolio value rose 62% quarter-over-quarter to $2.44B.
Based on Squarepoint's 13F filing for Q4 2016, filed 14 Feb 2017.